Dihydropteridine reductase deficiency (Q105033): Difference between revisions
From determinar.ia.br - Determine suas informações
Changed an Item |
Changed an Item |
||||||||||||||
| (One intermediate revision by the same user not shown) | |||||||||||||||
| Property / Knowledge Architect | |||||||||||||||
| Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Collection date | |||||||||||||||
16 August 2026
| |||||||||||||||
| Property / Collection date: 16 August 2026 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 10:56, 17 August 2026
Dihydropteridine reductase (DHPR) deficiency, an autosomal recessive genetic disorder, is one of the causes of malignant hyperphenylalaninemia due to tetrahydrobiopterine deficiency, and is also responsible for defective neurotransmission of monoamines. When left untreated, DHPR deficiency leads to neurological signs that include: psychomotor retardation, tonicity disorders, drowsiness, irritability, abnormal movements, hyperthermia, hypersalivation, and difficult swallowing.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_1931239861 |
||
| English | Dihydropteridine reductase deficiency |
Dihydropteridine reductase (DHPR) deficiency, an autosomal recessive genetic disorder, is one of the causes of malignant hyperphenylalaninemia due to tetrahydrobiopterine deficiency, and is also responsible for defective neurotransmission of monoamines. When left untreated, DHPR deficiency leads to neurological signs that include: psychomotor retardation, tonicity disorders, drowsiness, irritability, abnormal movements, hyperthermia, hypersalivation, and difficult swallowing. |
Statements
CID11:ID_1931239861
0 references
dki-india-ID_1931239861
0 references
Concluído
0 references
16 August 2026
0 references
